Clinical Trial Update: Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata

View source ↗

Summary

A completed clinical trial conducted at Benha University examined whether the NR3C1 rs41423247 (BclI) polymorphism influences disease severity in alopecia areat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Snippet

Sponsor: Benha University | Conditions: Alopecia Areata(AA) | Status: COMPLETED